What is NDC 50633-330?

50633-330 is the product NDC for Xuriden (uridine triacetate), Uridine triacetate 951 mg/g granule, listed with the FDA by BTG International Inc. It has 1 package NDC, shown above in 10- and 11-digit form.

BTG International Inc, NDC labeler code 50633. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Xuriden?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Xuriden NDC 50633-330 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)50633-330Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50633-0330Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50633-330-30	5063303303050633033030	30 PACKET in 1 CARTON (50633-330-30) / 2 g in 1 PACKET (50633-330-02)Marketed from May 31, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Xuriden
Generic name (nonproprietary): uridine triacetate
Active ingredients: Uridine triacetate — 951 mg/g
Dosage form: Granule
Route: Oral
Labeler: BTG International IncNDC labeler code 50633
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208169
Marketing start: May 31, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Analogs/Derivatives (Chemical/Ingredient)Pyrimidines (Chemical/Ingredient)
Identifiers: Product ID 50633-330_2e671cf8-09be-ac40-e063-6294a90aaf8fSPL ID 2e671cf8-09be-ac40-e063-6294a90aaf8fSPL set ID 88ca4d2b-3905-474b-9fd6-c81474f2fb4bRxCUI 1665467, 1665473UNII 2WP61F175MUPC 0350633330020
Pharmacologic class: Pyrimidine Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450633033030 followed by a unit qualifier and the quantity

Package 50633-0330-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 18, 2025.

Indications (excerpt from the label)

XURIDEN ® is indicated in adult and pediatric patients for the treatment of hereditary orotic aciduria. XURIDEN is a pyrimidine analog for uridine replacement indicated in adult and pediatric patients for the treatment of hereditary orotic aciduria. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 50633-330

What is NDC 50633-330?: 50633-330 is the product NDC for Xuriden (uridine triacetate), Uridine triacetate 951 mg/g granule, listed with the FDA by BTG International Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Xuriden (Uridine triacetate).
What is the active ingredient?: Uridine triacetate.
Who is the labeler?: BTG International Inc, NDC labeler code 50633. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Xuriden?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Xuriden (Uridine triacetate) NDC 50633-330